We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$251M
AUM Growth
-$19M
Cap. Flow
-$2.24M
Cap. Flow %
-0.89%
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$962K
2
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$944K
3
ENPH icon
Enphase Energy
ENPH
+$834K
4
DVN icon
Devon Energy
DVN
+$751K
5
IT icon
Gartner
IT
+$742K

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$785K
2
LHX icon
L3Harris
LHX
+$740K
3
A icon
Agilent Technologies
A
+$713K
4
CPRT icon
Copart
CPRT
+$688K
5
CQP icon
Cheniere Energy
CQP
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 18.83%
2 Real Estate 17.55%
3 Materials 12.77%
4 Financials 9.88%
5 Energy 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRMY icon
301
Harmony Biosciences
HRMY
$2.08B
$235K 0.09%
5,296
+78
+1% +$3.81K
MAIN icon
302
Main Street Capital
MAIN
$5.11B
$232K 0.09%
6,909
-4,368
-39% -$180K
NKTR icon
303
Nektar Therapeutics
NKTR
$2.3B
$230K 0.09%
4,801
+70
+1% +$4.17K
MRNA icon
304
Moderna
MRNA
$21.9B
$229K 0.09%
1,940
-5,173
-73% -$785K
BCIC
305
BCP Investment Corp
BCIC
$87.9M
$228K 0.09%
10,846
-2,085
-16% -$47.9K
AMGN icon
306
Amgen
AMGN
$212B
$226K 0.09%
1,001
+16
+2% +$3.88K
RLMD icon
307
Relmada Therapeutics
RLMD
$539M
$226K 0.09%
6,118
+50
+0.8% +$1.39K
UTHR icon
308
United Therapeutics
UTHR
$25.9B
$226K 0.09%
1,077
+14
+1% +$3.13K
SGEN
309
DELISTED
Seagen Inc. Common Stock
SGEN
$223K 0.09%
1,630
+26
+2% +$4.24K
INBX
310
DELISTED
Inhibrx, Inc. Common Stock
INBX
$220K 0.09%
12,263
+91
+0.7% +$1.64K
LEGN icon
311
Legend Biotech
LEGN
$3.65B
$218K 0.09%
5,351
+77
+1% +$3.61K
CRBU icon
312
Caribou Biosciences
CRBU
$146M
$215K 0.09%
20,369
+154
+0.8% +$1.44K
HALO icon
313
Halozyme
HALO
$9.88B
$214K 0.09%
5,400
+76
+1% +$3.36K
IRWD icon
314
Ironwood Pharmaceuticals
IRWD
$604M
$213K 0.08%
20,570
+303
+1% +$3.44K
GOSS icon
315
Gossamer Bio
GOSS
$96.9M
$210K 0.08%
17,496
+126
+0.7% +$1.56K
EXEL icon
316
Exelixis
EXEL
$14.1B
$209K 0.08%
13,327
+194
+1% +$3.75K
RARE icon
317
Ultragenyx Pharmaceutical
RARE
$2.53B
$206K 0.08%
4,965
+70
+1% +$3.6K
ROIV icon
318
Roivant Sciences
ROIV
$24B
$203K 0.08%
63,056
+927
+1% +$3.59K
ITCI
319
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$203K 0.08%
4,357
+61
+1% +$3.19K
ISEE
320
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$199K 0.08%
11,075
+78
+0.7% +$1.02K
MRCC
321
DELISTED
Monroe Capital Corp
MRCC
$198K 0.08%
27,284
-2,888
-10% -$25.3K
OXSQ icon
322
Oxford Square Capital
OXSQ
$148M
$196K 0.08%
65,045
-8,869
-12% -$32.6K
GERN icon
323
Geron
GERN
$917M
$191K 0.08%
81,613
+597
+0.7% +$1.34K
KZR
324
DELISTED
Kezar Life Sciences
KZR
$191K 0.08%
2,214
+17
+0.8% +$1.65K
AUPH icon
325
Aurinia Pharmaceuticals
AUPH
$1.92B
$187K 0.07%
24,920
+364
+1% +$3.15K
11 12
13
14 15

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Virtus ETF Advisers held 477 positions worth $251M, down 7% from $270M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Virtus ETF Advisers's Q3 2022 filing shows 43 new, 256 increased, 137 reduced and 41 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K. The largest sale was Moderna, an estimated $785K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

  • Virtus ETF Advisers's largest Q3 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K.
  • Virtus ETF Advisers added most to The Mosaic Company in Q3 2022, an estimated $962K increase.
  • Virtus ETF Advisers's biggest Q3 2022 reduction was Moderna, cutting an estimated $785K.
  • Virtus ETF Advisers fully exited L3Harris in Q3 2022, selling an estimated $740K.
  • Virtus ETF Advisers's ten largest holdings make up 7.1% of its $251M portfolio in Q3 2022.
  • Virtus ETF Advisers opened 43 new positions and closed 41 in Q3 2022.
  • Virtus ETF Advisers's portfolio value fell 7% quarter-over-quarter to $251M.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.